These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26813725)

  • 1. [Influential factors analysis on the survival time of patients infected with tuberculosis and HIV].
    Zheng Z; Tang Z; Lu Q; Wei H; Geng W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Oct; 49(10):907-13. PubMed ID: 26813725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
    Ni M; Chen X; Hu X; Ma Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania.
    Bwana V; Tenu F; Magesa SM; Mfinanga SG
    Tanzan J Health Res; 2011 Jan; 13(1):14-20. PubMed ID: 24409642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
    Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
    BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
    Azeez A; Mutambayi R; Odeyemi A; Ndege J
    Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
    Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
    Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
    BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antiretroviral therapy in reducing deaths among patients co-infected with Mycobacterium tuberculosis and human immunodeficiency virus in Guangxi].
    Zheng Z; Cui Z; Huang M; Pan D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Feb; 36(2):124-7. PubMed ID: 25907719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis].
    Zimina VN; Kravchenko AV
    Ter Arkh; 2015; 87(11):37-41. PubMed ID: 26821414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa.
    d'Elia A; Evans D; McNamara L; Berhanu R; Sanne I; Lönnermark E
    Pan Afr Med J; 2015; 22():4. PubMed ID: 26600904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study.
    Franke MF; Robins JM; Mugabo J; Kaigamba F; Cain LE; Fleming JG; Murray MB
    PLoS Med; 2011 May; 8(5):e1001029. PubMed ID: 21559327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
    Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
    PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
    Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
    AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
    Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
    BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.
    Manosuthi W; Chottanapand S; Thongyen S; Chaovavanich A; Sungkanuparph S
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):42-6. PubMed ID: 16885778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.